Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 18 Feb 2025 – 20 Aug 2026, limited by Axis Nifty500 Momentum 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty500 Momentum 50 Index Fund | Nifty 500 |
|---|---|---|
| 18 Feb 2025 | ₹100.00 | ₹100.00 |
| 05 Apr 2025 | ₹97.63 | ₹100.94 |
| 20 May 2025 | ₹110.00 | ₹109.58 |
| 05 Jul 2025 | ₹115.40 | ₹114.32 |
| 20 Aug 2025 | ₹111.14 | ₹112.28 |
| 04 Oct 2025 | ₹108.96 | ₹111.72 |
| 19 Nov 2025 | ₹115.29 | ₹115.99 |
| 04 Jan 2026 | ₹112.52 | ₹116.92 |
| 18 Feb 2026 | ₹111.71 | ₹114.72 |
| 05 Apr 2026 | ₹99.06 | ₹101.59 |
| 21 May 2026 | ₹110.89 | ₹109.66 |
| 05 Jul 2026 | ₹111.28 | ₹113.05 |
| 20 Aug 2026 | ₹114.89 | ₹114.08 |
| Metric | Axis · Regular NAV ₹11.13 Very High risk ★★☆☆☆ 1Y | Category median Index Funds · 366 funds |
|---|---|---|
| +3.37% | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +9.69% | +7.40% | |
| +6.06% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 18.72% | 13.88% | |
| -0.17 | 0.25 | |
| -0.24 | 0.35 | |
| -17.57% | -16.66% | |
| Nifty 500 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.66% | 0.96% | |
| ₹149.56Cr | ₹182.17Cr | |
| 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 35% | |
| Karthik Kumar | — | |
| 18 Feb 2025 | — | |
| 50 | — | |
| 46.1% | — | |
| -4.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.